Dennis L Winger - Net Worth and Insider Trading
Dennis L Winger Net Worth
The estimated net worth of Dennis L Winger is at least $4 Million dollars as of 2024-11-13. Dennis L Winger is the Director of Vertex Pharmaceuticals Inc and owns about 6,500 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $3 Million. Dennis L Winger is the Senior Vice President and CFO of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA and owns about 34,161 shares of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) stock worth over $785,020. Dennis L Winger is also the Director of Accuray Inc and owns about 89,100 shares of Accuray Inc (ARAY) stock worth over $169,736. Besides these, Dennis L Winger also holds Nektar Therapeutics (NKTR) . Details can be seen in Dennis L Winger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis L Winger has not made any transactions after 2018-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis L Winger
Dennis L Winger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis L Winger owns 5 companies in total, including Nektar Therapeutics (NKTR) , Accuray Inc (ARAY) , and Pacira BioSciences Inc (PCRX) among others .
Click here to see the complete history of Dennis L Winger’s form 4 insider trades.
Insider Ownership Summary of Dennis L Winger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2018-08-21 | director |
| ARAY | Accuray Inc | 2013-03-05 | director |
| PCRX | Pacira BioSciences Inc | 2013-09-11 | director |
 | | 2010-02-16 | director |
| | 2003-07-25 | director |
Dennis L Winger Latest Holdings Summary
Dennis L Winger currently owns a total of 4 stocks. Among these stocks, Dennis L Winger owns 6,500 shares of Vertex Pharmaceuticals Inc (VRTX) as of February 16, 2010, with a value of $3 Million and a weighting of 75.78%. Dennis L Winger owns 34,161 shares of Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) as of May 4, 2006, with a value of $785,020 and a weighting of 18.68%. Dennis L Winger also owns 89,100 shares of Accuray Inc (ARAY) as of March 5, 2013, with a value of $169,736 and a weighting of 4.04%. The other 1 stocks Nektar Therapeutics (NKTR) have a combined weighting of 1.5% among all his current holdings.
Latest Holdings of Dennis L Winger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2010-02-16 | 6,500 | 490.00 | 3,185,000 |
| ABI | Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA | 2006-05-04 | 34,161 | 22.98 | 785,020 |
| ARAY | Accuray Inc | 2013-03-05 | 89,100 | 1.91 | 169,736 |
| NKTR | Nektar Therapeutics | 2018-08-21 | 47,750 | 1.32 | 63,030 |
Holding Weightings of Dennis L Winger
Dennis L Winger Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis L Winger has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the acquisition of 6,500 shares on February 16, 2010, which cost Dennis L Winger around $250,510.
According to the SEC Form 4 filings, Dennis L Winger has made a total of 0 transactions in Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA (ABI) over the past 5 years. The most-recent trade in Safety First Trust Series 2009-2 GTD Principal Protected Tr CTF Lkd To The DJIA is the sale of 3,886 shares on May 4, 2006, which brought Dennis L Winger around $112,383.
According to the SEC Form 4 filings, Dennis L Winger has made a total of 0 transactions in Accuray Inc (ARAY) over the past 5 years. The most-recent trade in Accuray Inc is the acquisition of 20,000 shares on March 5, 2013, which cost Dennis L Winger around $86,000.
More details on Dennis L Winger's insider transactions can be found in the Insider Trading History of Dennis L Winger table.Insider Trading History of Dennis L Winger
- 1
Dennis L Winger Trading Performance
GuruFocus tracks the stock performance after each of Dennis L Winger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis L Winger is -2.77%. GuruFocus also compares Dennis L Winger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis L Winger within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis L Winger's insider trading performs compared to the benchmark.
Performance of Dennis L Winger
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.64 | | | | | |
| Relative Return to S&P 500(%) | 10.22 | | | | | |
Dennis L Winger Ownership Network
Ownership Network List of Dennis L Winger
Ownership Network Relation of Dennis L Winger
Dennis L Winger Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Dennis L Winger is the director of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Dennis L Winger made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Dennis L Winger Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis L Winger. Currently GuruFocus does not have mailing address information for Dennis L Winger.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
